Leptin is commonly thought to play a detrimental role in exacerbating experimental autoimmune encephalomyelitis (EAE) and multiple sclerosis. Paradoxically, we show here that astrocytic leptin signaling has beneficial effects in reducing disease severity. In the astrocyte specific leptin receptor knockout (ALKO) mouse in which leptin signaling is absent in astrocytes, there were higher EAE scores (more locomotor deficits) than in the wildtype counterparts. The difference mainly occurred at a late stage of EAE when wildtype mice showed signs of recovery whereas ALKO mice continued to deteriorate. The more severe symptoms in ALKO mice coincided with more infiltrating cells in the spinal cord and perivascular brain parenchyma, more demyelination, more infiltrating CD4 cells, and a lower percent of neutrophils in the spinal cord 28 days after EAE induction. Cultured astrocytes from wildtype mice showed increased adenosine release in response to interleukin-6 and the hippocampus of wildtype mice had increased adenosine production 28 days after EAE induction, but the ALKO mutation abolished the increase in both conditions. This indicates a role of astrocytic leptin in normal gliotransmitter release and astrocyte functions. The worsening of EAE in the ALKO mice in the late stage suggests that astrocytic leptin signaling helps to clear infiltrating leukocytes and reduce autoimmune destruction of the CNS.
Introduction
Multiple sclerosis (MS) is associated with elevated serum leptin concentrations (Frisullo et al., 2007) , and resolution of MS symptoms correlates with a decrease of serum leptin (Batocchi et al., 2003; Angelucci et al., 2005) . In a commonly used mouse model of MS, experimental autoimmune encephalomyelitis (EAE), leptin appears to play a deleterious role in conferring disease susceptibility after peripheral delivery (Matarese et al., 2001) , and use of blocking antibodies or soluble leptin receptor benefits EAE (Matarese et al., 2005; De Rosa et al., 2006) .
There are situations, however, in which a polypeptide plays opposite roles in the CNS and periphery, with cell type specific actions (Banks and Kastin, 1993; Kastin and Pan, 2010; Pan et al., 2012b) . Once produced by fat cells and released into the circulation, leptin can cross the blood-brain barrier (BBB) by receptormediated transport (Banks et al., 1996; Pan and Kastin, 2007) . In EAE, not only is BBB permeability increased in general (Juhler et al., 1984; Pan et al., 1996) , but leptin transport is increased selectively (Hsuchou et al., 2013) . In the CNS, leptin may act on either neurons or glial cells, and astrocytic signaling may differ from neuronal signaling as has been suggested in several models. While leptin provides neuroprotection (Farr et al., 2006; Garza et al., 2008; Tang, 2008) , inhibition of astrocytic activity accentuates neuronal leptin signaling, indicating antagonistic roles of astrocytes and neurons in leptin processing (Pan et al., 2011) . Astrocyte-specific leptin receptor knockout (ALKO) mice with a mutant membrane-bound leptin receptor lacking signaling function (Hsuchou et al., 2011) show more resistance to seizure induction (Jayaram et al., 2013a) . This is opposite from the alleviation of seizure severity after leptin treatment by intranasal delivery (Xu et al., 2008) , and is more consistent with a proconvulsive role of leptin after intracerebroventricular delivery (Ayyildiz et al., 2006) . The results suggest that astrocytic leptin signaling may play counter-regulatory roles with an effect opposite from that seen after systemic delivery of leptin.
Having shown that the astrocytic leptin receptor (ObR) is upregulated in EAE mice (Wu et al., 2013) , we hypothesized that leptin enhances astrocytic leptin signaling to modulate the recovery of mice from EAE. This predicted beneficial effect of astrocytic leptin signaling is supported by findings from a few analogous models. A crucial role of astrocytic gp130 signaling in ameliorating EAE has been shown. Astrocytes in the GFAP-Cre gp130(fl/fl) mice are apoptotic, rather than developing reactive gliosis as in WT mice. These astrocytic gp130 knockout mice have more demyelination and CD4 + T cell infiltration, as well as changed T cell subtype composition (Haroon et al., 2011) . The results indicate a protective
